Abiopharma

Cowie Robin Harper 🟢 acquired 29.0K shares (1 derivative) of BIODESIX INC (BDSX) at $6.46 Transaction Date: Jan 02, 2026 | Filing ID: 000065

📋 Badawi David (Officer) plans to sell 4K shares of Sight Sciences, Inc. (at $7.48 each, total $28K) Filed: Jan 06, 2026 | ID: 000155

Vazquez Chris 🟢 acquired 12.0K shares (1 derivative) of BIODESIX INC (BDSX) at $6.46 Transaction Date: Jan 02, 2026 | Filing ID: 000064

(99% Neutral) PRAXIS PRECISION MEDICINES, INC. (PRAX) Reports Q1 2026 Financial Results

📋 Rodberg James (Officer) plans to sell 594 shares of Sight Sciences, Inc. (at $7.48 each, total $4K) Filed: Jan 06, 2026 | ID: 000154

📋 Almstead Zheng Yang (Member of immediate family of any of the foregoing) plans to sell 54 shares of PTC THERAPEUTICS, INC. (at $76.95 each, total $4K) Filed: Jan 06, 2026 | ID: 000153

Martin Samuel Bates 🟡 adjusted position in 0 shares (1 derivative) of Celldex Therapeutics, Inc. (CLDX) at $10.38 Transaction Date: Jan 02, 2026 | Filing ID: 000002

New Form 424B3 - Enlivex Therapeutics Ltd. Filed: 2026-01-06 AccNo: 0001213900-26-001806 Size: 242 KB

Odrich Marc 🟢 acquired 98.2K shares (2 derivative) of LENZ Therapeutics, Inc. (LENZ) at $16.00 ($1.3M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

Chevallard Daniel R. 🟢 acquired 98.2K shares (2 derivative) of LENZ Therapeutics, Inc. (LENZ) at $16.00 ($1.3M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

Director Schimmelpennink Evert B. 🟢 acquired 358.1K shares (1 derivative) of LENZ Therapeutics, Inc. (LENZ) at $16.00 ($5.7M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

New Form DEFA14A - Quipt Home Medical Corp. Filed: 2026-01-06 AccNo: 0001104659-26-001323 Size: 35 KB

Director Zoghbi Huda Y 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

New Form 3 - Royalty Pharma plc Filed: 2026-01-06 AccNo: 0002096372-26-000004 Size: 300 KB

(99% Neutral) Quipt Home Medical Corp. (QIPT) Files Form 8-K